Cetera Investment Advisers Vertex Pharmaceuticals Inc Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 53,629 shares of VRTX stock, worth $21.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

53,629

Previous 52,013 3.11%

Holding current value

$21.9 Million

Previous $24.4 Million 2.31%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $743,360 - $817,340	1,616 Added 3.11%	53,629 $24.9 Million
Q2 2024 Aug 22, 2024	BUY	$392.81 - $485.53 $450,160 - $556,417	1,146 Added 2.25%	52,013 $24.4 Million
Q1 2024 May 24, 2024	BUY	$407.69 - $446.08 $14.9 Million - $16.3 Million	36,562 Added 255.59%	50,867 $21.3 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $1.24 Million - $1.35 Million	-3,032 Reduced 17.49%	14,305 $5.98 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $525,133 - $628,751	1,531 Added 9.69%	17,337 $7.05 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $143,726 - $154,045	425 Added 2.76%	15,806 $5.5 Million
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $460,310 - $515,196	1,464 Added 10.52%	15,381 $5.41 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $300,223 - $342,486	-1,060 Reduced 7.08%	13,917 $4.38 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.49 Million - $1.67 Million	5,200 Added 53.19%	14,977 $4.33 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $257,674 - $287,503	-941 Reduced 8.78%	9,777 $2.83 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $797,924 - $993,499	-3,396 Reduced 24.06%	10,718 $3.02 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $120,452 - $141,967	544 Added 4.01%	14,114 $3.68 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $55,227 - $69,716	-312 Reduced 2.25%	13,570 $2.98 Million
Q3 2021 Nov 16, 2021	SELL	$181.39 - $202.99 $148,558 - $166,248	-819 Reduced 5.57%	13,882 $2.52 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $162,741 - $191,914	868 Added 6.27%	14,701 $2.96 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $697,243 - $812,732	-3,368 Reduced 19.58%	13,833 $2.97 Million
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $2.52 Million - $3.36 Million	12,157 Added 241.02%	17,201 $4.07 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $955,619 - $1.13 Million	3,738 Added 286.22%	5,044 $1.37 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $294,476 - $386,314	1,306 New	1,306 $379,000
Q4 2018 Feb 15, 2019	SELL	$151.91 - $192.21 $171,354 - $216,812	-1,128 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $189,199 - $217,410	1,128 New	1,128 $217,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Vertex Pharmaceuticals Inc Transaction History